- Home
- GV vs RDHL Comparison
GV vs RDHL Comparison
Compare GV & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- RDHL
- Stock Information
- Founded
- GV 2013
- RDHL 2009
- Country
- GV Canada
- RDHL Israel
- Employees
- GV N/A
- RDHL N/A
- Industry
- GV Other Consumer Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- RDHL Health Care
- Exchange
- GV Nasdaq
- RDHL Nasdaq
- Market Cap
- GV 7.8M
- RDHL 4.3M
- IPO Year
- GV 2022
- RDHL N/A
- Fundamental
- Price
- GV $1.87
- RDHL $2.10
- Analyst Decision
- GV
- RDHL
- Analyst Count
- GV 0
- RDHL 0
- Target Price
- GV N/A
- RDHL N/A
- AVG Volume (30 Days)
- GV 53.6K
- RDHL 18.8K
- Earning Date
- GV 08-14-2025
- RDHL 08-28-2025
- Dividend Yield
- GV N/A
- RDHL N/A
- EPS Growth
- GV N/A
- RDHL N/A
- EPS
- GV N/A
- RDHL N/A
- Revenue
- GV $7,773,905.00
- RDHL $8,042,999.00
- Revenue This Year
- GV N/A
- RDHL $381.91
- Revenue Next Year
- GV N/A
- RDHL N/A
- P/E Ratio
- GV N/A
- RDHL N/A
- Revenue Growth
- GV N/A
- RDHL 23.17
- 52 Week Low
- GV $1.00
- RDHL $1.71
- 52 Week High
- GV $9.60
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- GV 51.61
- RDHL 61.27
- Support Level
- GV $1.61
- RDHL $2.00
- Resistance Level
- GV $1.79
- RDHL $2.08
- Average True Range (ATR)
- GV 0.15
- RDHL 0.09
- MACD
- GV 0.02
- RDHL 0.03
- Stochastic Oscillator
- GV 79.47
- RDHL 100.00
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.